Authors:
GRIESE EU
ZANGER UM
BRUDERMANNS U
GAEDIGK A
MIKUS G
MORIKE K
STUVEN T
EICHELBAUM M
Citation: Eu. Griese et al., ASSESSMENT OF THE PREDICTIVE POWER OF GENOTYPES FOR THE IN-VIVO CATALYTIC FUNCTION OF CYP2D6 IN A GERMAN POPULATION, Pharmacogenetics, 8(1), 1998, pp. 15-26
Citation: K. Morike et al., VARIABILITY IN THE FREQUENCY OF CYTOCHROME P450-2D6 (CYP2D6) DEFICIENCY, British journal of clinical pharmacology, 46(1), 1998, pp. 87-87
Citation: K. Morike et al., DRUG-THERAPY INFORMATION - A SERVICE PROVIDED BY CLINICAL PHARMACOLOGISTS FOR PHYSICIANS IN PRIVATE-PRACTICE AND HOSPITALS, European Journal of Clinical Pharmacology, 54(7), 1998, pp. 573-574
Authors:
SCHRENK D
BROCKMEIER D
MORIKE K
BOCK KW
EICHELBAUM M
Citation: D. Schrenk et al., A DISTRIBUTION STUDY OF CYP1A2 PHENOTYPES AMONG SMOKERS AND NONSMOKERS IN A COHORT OF HEALTHY CAUCASIAN VOLUNTEERS, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 361-367
Citation: G. Mikus et al., HEROIN SUBSTITUTION THERAPY - PHARMACOKINETICS OF DIHYDROCODEINE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4728-4728
Citation: K. Morike et al., USE OF AMINOGLYCOSIDES IN ELDERLY PATIENTS - PHARMACOKINETIC AND CLINICAL CONSIDERATIONS, Drugs & aging, 10(4), 1997, pp. 259-277
Citation: M. Koch et al., DETECTION OF SMALL TRACES OF N-15(2) AND N-14(2) BY FARADAY LMR SPECTROSCOPY OF THE CORRESPONDING ISOTOPOMERS OF NITRIC-OXIDE, Applied physics. B, Lasers and optics, 64(6), 1997, pp. 683-688
Authors:
VOLFF JN
TITTELBACH V
GIRAY J
LEMKE P
SCHWAB M
MORIKE K
RATGE D
WISSER H
Citation: Jn. Volff et al., HUMAN CARDIAC TYPE-V AND TYPE-VI ADNEYLYL CYCLASES - PARTIAL CDNA SEQUENCE AND RT-PCR DETECTION OF MESSENGER-RNAS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 217-217
Authors:
MORIKE K
SCHWAB M
MIKUS G
BOSEN N
EICHELBAUM M
Citation: K. Morike et al., A DRUG-THERAPY INFORMATION-SERVICE FOR PRACTITIONERS IN NORTHERN WURTTEMBERG - FIRST EXPERIENCES WITH A HOTLINE, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 447-447
Authors:
RODER F
SCHWAB M
VOGGENREITER B
BERNER V
ALEKER T
MORIKE K
KLOTZ U
THON KP
Citation: F. Roder et al., BENZODIAZEPINE USE IN PATIENTS WITH FRACTURES OF THE PROXIMAL FEMUR -DETECTION IN SERUM VERSUS DRUG HISTORY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 448-448
Authors:
TITTELBACH V
VOLFF JN
LEMKE P
SCHWAB M
MORIKE K
GIRAY J
RATGE D
WISSER H
Citation: V. Tittelbach et al., EXPRESSION OF G-PROTEINS IN PATIENTS WITH AND WITHOUT ATRIAL-FIBRILLATION FOLLOWING AORTOCORONARY BYPASS-SURGERY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 482-482
Authors:
DARBAR D
DELLORTO S
MORIKE K
WILKINSON GR
RODEN DM
Citation: D. Darbar et al., DIETARY SALT INCREASES FIRST-PASS ELIMINATION OF ORAL QUINIDINE, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 292-300
Citation: D. Darbar et al., EPINEPHRINE-INDUCED CHANGES IN SERUM POTASSIUM AND CARDIAC REPOLARIZATION AND EFFECTS OF PRETREATMENT WITH PROPRANOLOL AND DILTIAZEM, The American journal of cardiology, 77(15), 1996, pp. 1351-1355
Authors:
MORIKE K
MAGADUM S
METTANG T
GRIESE EU
MACHLEIDT C
KUHLMANN U
Citation: K. Morike et al., PROPAFENONE IN A USUAL DOSE PRODUCES SEVERE SIDE-EFFECTS - THE IMPACTOF GENETICALLY-DETERMINED METABOLIC STATUS ON DRUG-THERAPY, Journal of internal medicine, 238(5), 1995, pp. 469-472
Authors:
BOCK KW
SCHRENK D
FORSTER A
GRIESE EU
MORIKE K
BROCKMEIER D
EICHELBAUM M
Citation: Kw. Bock et al., THE INFLUENCE OF ENVIRONMENTAL AND GENETIC-FACTORS ON CYP2D6, CYP1A2 AND UDP-GLUCURONOSYLTRANSFERASES IN MAN USING SPARTEINE, CAFFEINE, ANDPARACETAMOL AS PROBES, Pharmacogenetics, 4(4), 1994, pp. 209-218